TGFB1 and diabetic kidney disease: In both patients and animal models of DKD, the TGF-β ligands, type 2 transmembrane receptor (TGFBRs), and downstream signaling molecules, such as Smad2 and Smad3, were profoundly upregulated or activated within glomeruli, tubules, and the tubulointerstitium [136].